Disclosure: Bullpen receives compensation from VersaBank for research coverage. VersaBank is also an IR client of LodeRock Advisors, an affiliate of Bullpen.

TSX
1D %
YTD %
36,170.45
0.8%
13.5%
TSXV
1D %
YTD %
822.09
1.7%
17.2%
S&P 500
1D %
YTD %
7,520.93
0.4%
9.7%
NASDAQ
1D %
YTD %
25,065.88
0.7%
7.9%
US 10Y
1D
YTD
4.99
10 bps
86 bps
DJIA
1D %
YTD %
52,231.89
0.3%
8.0%
CA 10Y
1D
YTD
3.72
6 bps
28 bps
CAD/USD
1D %
YTD %
0.705
0.5%
3.2%

Lest we forget. Today, we pause to honour and remember those who served and sacrificed for our freedom.

WHAT'S ON TAP

HOT OFF THE PRESS

Strathcona’s $2.8B deal and $3B rail proposal

Just a month after Cenovus bought Athabasca for $5.7B, we’ve got more heavy oil consolidation - with Strathcona (SCR) acquiring Greenfire in a $2.8B deal which adds 30% to production…

… and 40% to reserves, while increasing the pro-forma entity’s reserve life index to 54 years (the longer the duration the better).

With $2.8B of tax pools and $75M of run-rate synergies, there’s a clear financial rationale to the deal (which we expected)…

… but the real benefit lies in its enhanced scale, which gives Strathcona the firepower to chase larger capital projects like its $3B Northern Express partnership with CN Rail. If approved, it would send 250K barrels per day to BC’s northern coast…

… increasing Asian market access together with the Pacific Link pipeline, though it still has the tanker ban to deal with.

VersaBank hits US$1B SRP funding target early

VersaBank (VBNK) added another ~5% since hitting its US$1B SRP funding target early, adding $969M in assets Q/Q (above our estimates)…

… driven by demand for the real-time program, which bodes well for its US$3B 2027 funding target and for earnings contribution from south of the border.

With its US operation being the bank’s most efficient by a wide margin…

… continued outperformance in the growth of VersaBank’s SRP assets would drive upside versus our forecasts and should translate to ROE acceleration…

… as the operating leverage in its soon-to-be home market enables VBNK to earn more on its equity capital, driving growth in book value per share and multiple expansion.

ON OUR RADAR

GAINERS & LOSERS

Chorus (CHR)
1D %
YTD %
35.65
8.3%
66.2%
WELL Health (WELL)
1D %
YTD %
3.59
15.5%
10.0%
Pet Valu (PET)
1D %
YTD %
23.15
7.6%
17.0%
Rubellite (RBY)
1D %
YTD %
3.20
7.5%
33.3%
Trisura (TSU)
1D %
YTD %
30.88
4.8%
27.7%
GFL Environmental (GFL)
1D %
YTD %
60.15
7.2%
2.0%

GFL Environmental (GFL) fell 7% after concluding its review with no deal, giving back some of the post-rumour run…

… but not all of it, as investors refocus on GFL’s strong solid waste platform…

… with a straightforward path to scale through a combination of organic growth and tuck-in M&A, which adds density to its existing network and improves margins.

Management expects its go-forward strategy will double FCF per share over the next five years - supporting that growth, leverage reduction plans, and an active buyback program…

… which the company has never had the financial capacity for in the past.

Chorus Aviation (CHR) ran 8% on its Q3 results, which beat clean and came with a guide for the company’s non-CPA revenue to roughly double between 2025-2027…

… on a combination of 5-10% organic growth and recent acquisitions. Given the segment runs at higher margins than Chorus’ total business…

… that should support continued buyback activity, given leverage sits comfortably within management’s 1-2x target range.

Future M&A could also be on the table, with an active opportunity pipeline…

❝

There are opportunities that we’re working through right now that we feel very good about, that fit very well and fit all the parameters we’ve talked about as far as return metrics and so on.

Colin Copp (CEO) - CHR Q3/26 call

… and a multiple that could support equity issuance if necessary, assuming it can find targets at sub-5x EBITDA like its recent $40M SkyCare deal.

Was this forwarded to you? Join 10,000+ investors reading The Morning Meeting by clicking the button below.

About Bullpen: Bullpen Finance Inc. publishes content on Canadian markets and provides paid research coverage of select Canadian issuers. Bullpen is paid in cash by covered issuers, does not accept stock or options, does not hold positions in covered securities, and does not conduct investment banking business. Bullpen and LodeRock Advisors Inc. are affiliated; LodeRock provides investor relations services to issuers, some of whom are covered by Bullpen Research. When a post discusses a covered issuer, a specific disclosure appears at the top of the post. This post is published for general information purposes. It is not personalized investment advice and is not tailored to any individual reader’s circumstances. Bullpen is not a registered investment adviser or dealer. For full disclosures, including analyst certification, jurisdictional statements, and conflict of interest policies, please see our Legal & Disclosures section on our website.